AKYmed, a leading Swiss company specializing in male fertility analysis for both humans and animals, proudly announces its strategic partnership with Rara Avis Biotec, a leading biotechnology company specializing in the production of recombinant gonadotropins.
This collaboration marks a significant milestone in the field of animal reproduction, combining AKYmed’s cutting-edge technologies with Rara Avis Biotec’s expertise in recombinant gonadotropins and immunoassay methods.
Rara Avis Biotec is renowned for its production of over 40 recombinant gonadotropins specific to different species of teleost fishes, birds, reptiles, and mammals. These gonadotropins have demonstrated efficacy in inducing reproductive cycles, gonadal maturation, and collection of functional mature gametes in various vertebrate species.
AKYmed, established in 2019, specializes in male fertility analysis and offers a range of products and services including QualiSperm CASA for human and animal market, cryopreservation, biobanking, genomic analysis services, consumables, and peripherals. AKYmed’s Noah Genetics branch focuses on diagnosing, preserving, and optimizing genetic diversity in animal reproduction, catering to markets such as aquaculture, companion animal industry, and wildlife conservation.
